Is There A Benefit Of Oxaliplatin In Neoadjuvant Treatment Of Locally Advanced Rectal Cancer? An Updated Meta-Analysis.
JOURNAL OF CLINICAL ONCOLOGY(2020)
Abstract
4098Background: Neoadjuvant fluoropyrimidine (5FU or capecitabine)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition...
MoreTranslated text
Key words
Neoadjuvant Therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined